ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
AP-Lab: An AI-Driven Autonomous Pilot-Scale Platform Bridging Materials Discovery and Industrial Manufacturing.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Artificial intelligence (AI) has accelerated materials discovery, yet its translation to industrial manufacturing remains limited due to two critical gaps: the scarcity of proprietary industrial datasets and the absence of application-oriented benchmarks. To address these challenges, we develop the AP-Lab, an AI-Driven Autonomous Pilot-Scale Laboratory workstation designed to bridge research and manufacturing. Using magnetic nanoparticles (MNPs) for viral nucleic acids (NAs) extraction as a case study, the AP-Lab integrates four agent-controlled systems for user interaction, optimization scheme generation, autonomous synthesis and testing, and data management. By leveraging localized industrial datasets and adopting Polymerase Chain Reaction (PCR) cycle threshold (Ct) values as an application-specific benchmark, the AP-Lab achieves rapid optimization of MNPs-based NAs extraction products at pilot-scale corresponding to 50,000 tests per batch within three weeks, and enables scale-up manufacturing of 1 million tests per batch in two months. Compared to conventional manual workflows, the AP-Lab reduces development timelines from four to six months to three weeks while delivering performance superior to leading commercial products. This work demonstrates a scalable strategy for AI-driven pilot-scale production and offers a blueprint for accelerating industrial adoption of advanced materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.